Abstract
The effect of the calcium channel blocker (KB-2796) on metabolic and functional recovery in rabbit spinal cord after 20, 30, and 40 min ischemia and 4 days of recovery was investigated. The drug was given intraperitoneally in three different doses, 10, 20, or 50 mg/kg pre-or post-ischemia of 20, 30, or 40 min duration. Both higher doses 20 and 30 mg/kg completely recovered energy state and significantly improved neurological functions in the spinal cord following 20 and 30 min ischemia. Partial protection was observed even after 40 min ischemia. The protective effect of KB-2796 exceeds the effect of calcium blockers previously used in experimental spinal cord ischemia.
Similar content being viewed by others
References
Siesjo, B. K. 1992. Pathophysiology and treatment of focal cerebral ischemia. J. Neurosurg. 77:337–354.
Vaagenes, P., Cantadore, R., Safar, P., Moossy, J., Rao, G., Diven, W., Alexander, H., and Stezoski, W. 1984. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs. Crit. Care Med. 12:846–855.
Deshpande, J. K., and Wieloch, T. 1986. Flunarizine, a calcium entry blocker, ameliorates ischemic brain damage in the rat. Anesthesiology 64:215–224.
Steen, P. A., Gisvold, S. E., Milde, J. H., Newberg, L. A., Schauthauser, B. W., Lanier, W. L., and Michenfelder, J. D. 1985. Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 62:406–414.
Chavko, M., Kalincakova, K., Kluchova, D., and Nemoto, E. 1991. Blood flow and electrolytes in spinal cord ischemia. Exp. Neurol. 112:299–303.
Young, W., and Flamm, E. S. 1982. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury. J. Neurosurg. 57:667–673.
Faden, A. I., Jacobs, T. P., Smith, G. P., Green, B., and Zivin, J. A. 1983. Neuropeptides in spinal cord injury: comparative experimental models. Peptides 4:631–634.
Faden, A. I., Jacobs, T. P., and Smith, M. T. 1984. Evaluation of the calcium channel antagonist nimodipine in experimental spinal cord ischemia. J. Neurosurg. 60:796–799.
Kanazawa, T., Morita, T., Harada, K., and Ito, K. 1987. Selective effect of KB-2796, a new calcium antagonist, on cerebral circulation in anesthetized dogs. Jpn. J. Pharmacol. 43:98P.
Ito, K., Yoshidomi, M., Ozaki, A., Yamashita, A., Hayashi, A., and Sukamoto, T. 1987. Effect of KB-2796 on cerebral hypoxia/ischemia and memory deficit in animal models. 10th Int. Congr. Pharmacol. Pages 716, Sydney.
Yamashita, A., Hayashi, A., Ozaki, A., Sukamoto, T., and Ito, K. 1987. Effect of KB-2796 upon local cerebral glucose utilization in the rat brain. Jpn. J. Pharmacol. 43:98.
Danielisova, V., Marsala, M., Chavko, M., and Marsala, J. 1990. Postischemic hypoxia improve metabolic and functional recovery of the spinal cord. Neurology 40:1125–1129.
Anderson, D. K., Means, E. D., Waters, T. R., and Green, E. S. 1993. Susceptibility of feline spinal cord energy metabolism to severe incomplete ischemia. Neurology 33:722–731.
Folbergrova, J., Ljunggren, B., Norberg, K., and Siesjo, B. K. 1972. Influence of complete ischemia on glycolytic metabolites, citric acid intermediates, and associated amino acids in the rat cerebral cortex. Brain Res. 80:265–279.
Atkinson, D. E. 1968. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Br. J. Pharmacol. 7:4030–4032.
Zivin, J. A., DeGirolami, U., and Hurwitz, E. L. 1982. Spectrum of neurological deficit in experimental CNS ischemia. A quantitative study. Arch. Neurol. 39:408–412.
Yoshidomi, M., Hayashi, T., Abe, K., and Kogure, K. 1989. Effects of a new calcium channel blocker, KB-2796, on protein synthesis of the CA1 pyramidal cell and delayed neuronal death following transient forebrain ischemia. J. Neurochem. 53:1589–1594.
Harada, K., Nakasu, Y., Matsuda, H., and Handa, J. 1987. Effect of KB-2796 on the regional cerebral blood flow. Comparison with the effect of flunarizine. Jpn. Pharmacol. Ther. 15:1499–1506.
Kanazawa, T., Kidooka, M., Matsuda, M., and Handa, J. 1986. Effects of 1-[bis(4-flurophenyl)methyl]-4-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride, a new synthesized Ca2+ blocker KB-2796, on free fatty acid liberation in ischemic brain in rats. Arch. Jpn. Chir. 55:755–761.
Hansen, A. J., and Zeuthen, T. 1981. Extracellular ion concentrations during spreading depressing and ischemia in the brain cortex. Acta Physiol. Scand. 113:437–455.
Gelbfish, J. S., Phillips, T., Rose, D. M., Wait, R., and Cunningham, J. N. 1986. Acute spinal cord ischemia: prevention of paraplegia with verapamil. Circulation 74:I-5–I-10.
Danielisova, V., and Chavko, M. 1992. Amelioration of ischemic spinal cord damage by postischemic treatment with propentofylline. Brain Res. 590:321–324.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Danielisova, V., Chavko, M. KB-2796, a calcium channel blocker, ameliorates ischemic spinal cord damage in rabbits. Neurochem Res 19, 1503–1507 (1994). https://doi.org/10.1007/BF00968997
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00968997